Target intelligence / Profile preview

Serum protein corona (PC)

Target
PC
Molecular classification
Protein complex, Biomolecular interface, Other
01

Overview

The serum protein corona is a dynamic layer of proteins and other biomolecules that spontaneously adsorb onto the surface of nanoparticles when they come into contact with biological fluids such as blood or serum (Monopoli et al., 2012, Nature Nanotechnology). This corona defines the biological identity of the nanoparticle, which is what the biological environment actually interacts with, rather than the synthetic surface engineered by researchers (Walkey & Chan, 2012, Chemical Society Reviews). It is typically characterized by a hard corona of tightly bound proteins with slow exchange rates and a soft corona of loosely associated proteins with rapid exchange (Corbo et al., 2016, Nanomedicine). The composition of the corona significantly influences the nanoparticle's pharmacokinetics, biodistribution, and toxicity by modulating cellular uptake and immune recognition (Tenzer et al., 2013, Nature Nanotechnology). While not a traditional therapeutic target like a receptor or enzyme, the protein corona is a critical interface in nanomedicine that can either lead to rapid clearance by the mononuclear phagocyte system or be exploited for endogenous targeting to specific tissues.

Other names
Protein coronaNanoparticle-protein coronaBiomolecular coronaHard coronaSoft coronaPlasma protein corona
02

Mechanism of action

The serum protein corona modulates the biological identity of nanoparticles, influencing their interaction with cell surface receptors and immune cells, which determines their pharmacokinetic profile, biodistribution, and therapeutic efficacy.

03

Biological functions

OpsonizationCellular uptake modulationBiodistribution regulationImmune recognitionToxicity modulation
04

Disease associations

CancerInflammationOther
05

Safety considerations

Accelerated blood clearance (ABC) phenomenonImmunogenicityOff-target accumulationNanotoxicityLoss of targeting specificity
06

Interacting drugs

Doxorubicin (liposomal)

4 more in the full profile.

07

Biomarkers

Apolipoprotein EAlbuminComplement C3FibrinogenImmunoglobulin G

Beyond the preview

Go deeper on Serum protein corona (PC).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serum protein corona (PC).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call